BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shibui Y, Miyoshi K, Kohashi K, Kinoshita Y, Kuda M, Yamamoto H, Taguchi T, Oda Y. Glypican-3 expression in malignant small round cell tumors. Oncol Lett 2019;17:3523-8. [PMID: 30867793 DOI: 10.3892/ol.2019.9976] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Busato D, Mossenta M, Dal Bo M, Macor P, Toffoli G. The Proteoglycan Glypican-1 as a Possible Candidate for Innovative Targeted Therapeutic Strategies for Pancreatic Ductal Adenocarcinoma. IJMS 2022;23:10279. [DOI: 10.3390/ijms231810279] [Reference Citation Analysis]
2 Mao W, Xu J, Lu H, Wang Y, Zhang L, Chen M. A rare case report of renal ewing sarcoma/primitive neuroectodermal tumor with ACTH production. BMC Urol 2022;22:103. [PMID: 35821028 DOI: 10.1186/s12894-022-01055-y] [Reference Citation Analysis]
3 Qiang Z, Zhang H, Jin S, Yan C, Li Z, Tao L, Yu H. The prognostic value of arginase-1 and glypican-3 expression levels in patients after surgical intrahepatic cholangiocarcinoma resection. World J Surg Oncol 2021;19:316. [PMID: 34715880 DOI: 10.1186/s12957-021-02426-9] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Yan C, Yang Q, Zhang S, Millar DG, Alpert EJ, Do D, Veloso A, Brunson DC, Drapkin BJ, Stanzione M, Scarfò I, Moore JC, Iyer S, Qin Q, Wei Y, McCarthy KM, Rawls JF, Dyson NJ, Cobbold M, Maus MV, Langenau DM. Single-cell imaging of T cell immunotherapy responses in vivo. J Exp Med 2021;218:e20210314. [PMID: 34415995 DOI: 10.1084/jem.20210314] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Štefík P, Annušová A, Lakatoš B, Elefantová K, Čepcová L, Hofbauerová M, Kálosi A, Jergel M, Majková E, Šiffalovič P. Targeting acute myeloid leukemia cells by CD33 receptor-specific MoS2-based nanoconjugates. Biomed Mater 2021;16. [PMID: 34280914 DOI: 10.1088/1748-605X/ac15b1] [Reference Citation Analysis]